Capillary injury in the ischemic brain of hyperlipidemic, apolipoprotein B-100 transgenic mice

Life Sciences ◽  
2009 ◽  
Vol 84 (25-26) ◽  
pp. 935-939 ◽  
Author(s):  
Zoltán Süle ◽  
Éva Mracskó ◽  
Erika Bereczki ◽  
Miklós Sántha ◽  
Tamás Csont ◽  
...  
2001 ◽  
Vol 276 (44) ◽  
pp. 41526
Author(s):  
Jon H. Miyake ◽  
Xuan-Dao T. Doung ◽  
William Strauss ◽  
Gina L. Moore ◽  
Lawrence W. Castellani ◽  
...  

2007 ◽  
Vol 48 (12) ◽  
pp. 2597-2606 ◽  
Author(s):  
Enhui Wei ◽  
Mustafa Alam ◽  
Fengcheng Sun ◽  
Luis B. Agellon ◽  
Dennis E. Vance ◽  
...  

1996 ◽  
Vol 7 (1) ◽  
pp. 39-49 ◽  
Author(s):  
Steven D. Hughes ◽  
Didier Rouy ◽  
Naveenan Navaratnam ◽  
James Scott ◽  
Edward M. Rubin

2009 ◽  
Vol 89 (2) ◽  
pp. 178-186 ◽  
Author(s):  
Ferenc B. Sallo ◽  
Erika Bereczki ◽  
Tamás Csont ◽  
Philip J. Luthert ◽  
Peter Munro ◽  
...  

1995 ◽  
Vol 95 (5) ◽  
pp. 2246-2257 ◽  
Author(s):  
D A Purcell-Huynh ◽  
R V Farese ◽  
D F Johnson ◽  
L M Flynn ◽  
V Pierotti ◽  
...  

Stroke ◽  
2014 ◽  
Vol 45 (suppl_1) ◽  
Author(s):  
Wei Yang ◽  
Huaxin Sheng ◽  
Will Thompson ◽  
Shengli Zhao ◽  
Liangli Wang ◽  
...  

Background and Purpose: Small ubiquitin-like modifier (SUMO) conjugation modulates many key cellular processes. Transient cerebral ischemia dramatically activates SUMO2/3 conjugation, and this is believed to be a protective stress response. It is, therefore, of tremendous clinical interest to characterize the SUMO-modified proteome regulated by transient ischemia. We generated a novel SUMO transgenic mouse and performed the first SUMO proteomics study using post-ischemic brain samples. Methods: CAG-loxP-STOP-loxP-SUMO (CAG-SUMO) mice were generated in which His-SUMO1, HA-SUMO2, and FLAG-SUMO3 were expressed from a single multicistronic transgene in a Cre-dependent manner. CAG-SUMO mice were mated with Emx1 Cre/Cre mice to generate double transgenic CAG-SUMO/Emx1-Cre mice as experimental mice and Emx1 Cre/+ mice as control mice. Double transgenic mice were subjected to 10 min global cerebral ischemia followed by 1 h reperfusion or sham operation. FLAG-SUMO3-conjugated proteins were enriched from cortical tissues and analyzed. Results: Characterization of double transgenic mice demonstrated that exogenous expressed tagged SUMO paralogues were functionally intact and did not perturb the endogenous SUMOylation machinery in the brain. FLAG pulldown of cortical samples from sham and ischemia mice followed by GeLC-MS/MS analysis identified 91 candidates whose SUMOylation states were up-regulated in ischemic samples. Data analysis revealed several potentially important processes in which SUMO3 conjugation may play a key role during ischemia/reperfusion, including the cross-talk between SUMOylation and ubiquitination, glucocorticoid receptor signaling, and modulation of posttranscriptional mRNA processing. Conclusions: SUMO proteomic analysis identified important processes and pathways modulated by SUMOylation in the post-ischemic brain that warrant future investigations, since they could be the key to understand the overall impact of SUMOylation on the fate and functions of post-ischemic neurons. The conditional SUMO transgenic mouse will be an invaluable tool for in-depth in vivo analysis of the SUMO-modified proteome in various pathological states.


1994 ◽  
Vol 14 (4) ◽  
pp. 2243-2256
Author(s):  
A R Brooks ◽  
B P Nagy ◽  
S Taylor ◽  
W S Simonet ◽  
J M Taylor ◽  
...  

To identify DNA sequence elements from the human apolipoprotein B (apoB) gene required for high-level, correct tissue-specific expression in transgenic mice, we made several constructs that included one or more of the key regulatory elements that were previously characterized with cultured liver-derived and intestine-derived cell lines. Our data show that the apoB promoter alone (-898 to +121) is not sufficient to direct transcription in transgenic mice. An enhancer located in the second intron is absolutely required to specify transcription by the homologous apoB promoter in the livers of transgenic mice; this enhancer does not direct transcription in the small intestines. Thus, the elements controlling transcriptional activation of the apoB gene in the liver and the intestine in vivo are distinct and separable. Analysis of the DNase I hypersensitivity of the integrated human transgenes in various lines of expressing and nonexpressing mice suggests that the formation of DH4, a strong hypersensitive site in intron 2, may be a prerequisite for hepatic expression of the apoB gene. Nuclear matrix association regions (MARs) of the apoB gene may play a role in transgene expression. Constructs including MAR sequences displayed higher levels of expression than those lacking them. However, these MARs did not completely insulate the associated transgenes from position effects.


Sign in / Sign up

Export Citation Format

Share Document